Abraxis BioScience LLC, part of Bristol Myers Squibb Co., is a company headquartered in Los Angeles, CA, involved in commercial physical and biological research.

Sichuan Kelun Pharmacy Institute Co., Ltd., part of Sichuan Kelun Pharmaceutical Co., Ltd., is a company headquartered in Chengdu, China. The firm manufactures medicines. It was founded in 1998.

BIOVIIIx Srl is a private company headquartered in Italy. The firm operates as a biotechnology and pharmaceutical company which develops medicines for rare diseases.

ACS Dobfar is a privately held, chemical-pharmaceutical company that offers high quality pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms (oral and injectables). The company is committed to the production of Beta-lactam and Non Beta-lactam Anti-infectives, in particular Cephalosporins, Carbapenems, and Penicillins. It exports its products to more than 100 countries and employs more than 900 workers distributed over 6 production sites. ACS Dobfar was founded on 1973 and is headquartered in Agrate Brianza, Italy.

IMGT Corp. Ltd. develops innovative tumor treatment via image guided therapy. It specializes in ultrasound mediated drug (or) gene delivery method. The company was founded on April 5, 2010 and is headquartered in Seongnam, South Korea.

Changzhou Target Pharmaceutical Technology Co., Ltd., established on 2014-08-05, The scope of business includes engaging in pharmaceutical,Healthy food,Research and development of a class of medical devices;Provide relevant technical advice,Technology Transfer and Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

FAPESP is a public foundation, funded by the taxpayer in the State of São Paulo, with the mission to support research projects in higher education and research institutions, in all fields of knowledge. São Paulo has a population of forty million and generates 35% of Brazil’s GNP. The constitution of the State establishes that 1% of all state taxes belong to the foundation and the government transfers these funds monthly. The stability of the funding and the autonomy of the foundation allow for an efficient management of the resources that has had a sizable impact: while São Paulo has 22% of the Brazilian population and 30% of the scientists with a doctorate in the country, the state responds for 52% of the country’s scientific articles published in international journals. The Foundation works in close contact with the scientific community: all proposals are peer reviewed with the help of area panels composed of active researchers. Besides funding research in all fields, the foundation supports large research programs in Biodiversity, Bioenergy, Global Climate Change, and in Neurosciences.

Seoul National University Hospital (서울대학교병원) is one of the oldest and biggest hospitals in South Korea. It is a general and teaching hospital of Seoul National University's College of Medicine. Except SNUH Healthcare System Gangnam Center, all branches have an emergency department (ED).

Shanghai Letu Life Technology Co., Ltd., established on 2016-09-12, The scope of business includes engaging in genetic technology,Biological Technology,medical technology,Technology development in the field of medical science and technology,technical consulting,technology transfer,Technical Services,Wholesale of Class I Medical Devices,retail,Health Management Consulting. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

SN BioScience provide nano-formulation screening services for small molecule, oligonucleotide (siRNA, DNA), peptide and protein to deliver in the form of nano-micelle, nanoparticle or liposome. Their proprietary “double core-shell technology” and pool of acceptable lipids and polymers could help your research that having difficulties in solubility or delivery.

Beijing Renli Jinghe Biotechnology Co., Ltd., established on 2022-06-13, Business scope includes general items:Biochemical product technology research and development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Research and development of bio-based materials technology;Human stem cell technology development and application;Development of Human Gene Diagnosis and Therapy Technology;R&D and application of cell technology;Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;hospital management;business management;Business Management Consulting;Conference and Exhibition Services;Health Consulting Services(Does not include medical services);Cosmetics Wholesale;Cosmetics Retail;electronics sales;Household Appliances Repair.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Cosmetic production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Suzhou Yutai Pharmaceutical Technology Co., Ltd., established on 2019-09-30, Business scope includes technology development in the field of medical science and technology,technical consulting,technology transfer,Technical Services;wholesale:medicine,food,medical instruments;Engage in the import and export of the above commodities and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Part of CSPC Pharmaceutical Group Ltd., CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd. is a company headquartered in China. The firm engages in pharmaceutical research and development.

Shandong Hemeixin Animal Pharmaceutical Co., Ltd., established on 2009-09-30, Business scope includes production,Sales:powder/Powder/Premix,oral solution,disinfectant(solid,liquid);Production,Sell ​​Feed Additive Vitamins(II):vitaminsA,vitaminsB1,vitaminsB2,vitaminsC,vitaminsE,vitaminsK3;Production,Sales:additive premixed feed;Production,Sales:Plant extracts(Free of Hazardous Chemicals);Sales:Raw materials for veterinary medicine,feed ingredients(Free of Hazardous Chemicals);Import and export of goods permitted by the state.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nanjing Congyi Pharmaceutical Technology Co., Ltd., established on 2006-07-04, Business scope includes medical technology development and transfer,Medical Technology Services,Medical Consulting Services;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export);clinical research(Does not include diagnosis and treatment);Development and transfer of new medical technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shandong Target Drug Research Co., Ltd., established on 2006-11-10, The business scope includes Chinese and Western medicines,Health products,Research and Development of Medical Devices(Except for special regulations of the state).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Guangzhou Fuda Cancer Hospital is a tertiary specialized cancer hospital which is affiliated with the Health Department of Guangdong Province in China. It was designated a national key clinical (cancer) hospital by the National Health and Family Planning Commission in 2011. The same year, Guangzhou Fuda Cancer Hospital was honored with National Trustworthy Private Hospital by the National Institute of Hospital Administration. In 2012, China Hospital Association rated Guangzhou Fuda Cancer Hospital as China Public Confidence Model Hospital. It was accredited by JCI in 2014.

Shanghai Taishen Pharmaceutical Technology Co., Ltd., established on 2010-02-10, Business scope includes technology development in the professional field of medical science and technology,technical consulting,Technical Services,technology transfer;cosmetic,Chemical Products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),Electronic instrumentation,Electronic Equipment Sales. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]